🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆
Sreepriya Prasannan

Sreepriya Prasannan

Life Science Journalist & Editor

Sreepriya Prasannan is the Founder and Editor of Priya Life Science, Ireland's independent pharma, biotech and MedTech platform. She holds an MSc in Digital Transformation (Life Science) from Griffith College Dublin, with a background in QA, GMP and production operations. Shortlisted for STEM Graduate of the Year at the Business Post Women in STEM Awards 2026 and a Top 14 finalist in the HSE Spark Ignite 2026 innovation programme, she writes on regulatory trends, GMP compliance and careers across the Irish and European life sciences.

222
Articles
7
Topics
1444
Min Published
LinkedIn
Filter: All 222 Industry 101 Regulatory Affairs 42 Pharmaceutical 30 Biotechnology 16 MedTech 16 LinkedIn 12 Clinical Trials 5

All Articles

Page 9 of 19 — 222 articles
Media Fill Validation: Guidelines for Simulating Aseptic Liquid Processing Operations
Pharmaceutical
Media Fill Validation: Guidelines for Simulating Aseptic Liquid Processing Operations
A review of aseptic process simulation (APS), growth media selection, incubation parameters, and contamination limits in media fill validation.
29 Jun 2026 4 min
Navigating Global Price Controls: How the US Inflation Reduction Act and Evolving EU Policies Shape R&D in 2026
Regulatory Affairs
Navigating Global Price Controls: How the US Inflation Reduction Act and Evolving EU Policies Shape R&D in 2026
As global health systems enforce tighter pricing controls under the US IRA and EU health technology updates, biopharma majors are restructuring their R&D portfolios to manage clinical risks.
29 Jun 2026 6 min
An Introduction to Lyophilization (Freeze-Drying) Technology and Cycle Development in Biopharma
Pharmaceutical
An Introduction to Lyophilization (Freeze-Drying) Technology and Cycle Development in Biopharma
An academic analysis of the freeze-drying process, sublimation phases, critical chamber controls, and lyophilized formulation parameters.
29 Jun 2026 5 min
Data Integrity in the Pharmaceutical Quality Control Laboratory: ALCOA+ Principles Explained
Regulatory Affairs
Data Integrity in the Pharmaceutical Quality Control Laboratory: ALCOA+ Principles Explained
An educational review of data integrity requirements in pharma QC, covering ALCOA+ principles, audit trails, and data security.
29 Jun 2026 5 min
Out of Specification (OOS) Investigations: Step-by-Step Root Cause Analysis and CAPA Guidelines
Regulatory Affairs
Out of Specification (OOS) Investigations: Step-by-Step Root Cause Analysis and CAPA Guidelines
A structured tutorial on handling quality control laboratory OOS results, conducting Phase I/II investigations, and implementing corrective actions.
29 Jun 2026 5 min
Therapeutic Hotspots of 2026: Evolving Pipelines in Antibody-Drug Conjugates (ADCs) and GLP-1 Obesity Platforms
Regulatory Affairs
Therapeutic Hotspots of 2026: Evolving Pipelines in Antibody-Drug Conjugates (ADCs) and GLP-1 Obesity Platforms
Global research pipelines and venture capital inflows are concentrating in targeted cancer therapy with ADCs and next-generation cardiometabolic GLP-1 oral weight-loss compounds.
29 Jun 2026 4 min
Computer Systems Validation (CSV): Implementing the GAMP 5 Lifecycle Framework in Modern Plants
Regulatory Affairs
Computer Systems Validation (CSV): Implementing the GAMP 5 Lifecycle Framework in Modern Plants
A guide to validating computerized lab and production systems using the GAMP 5 V-model lifecycle, risk assessments, and electronic records compliance.
29 Jun 2026 5 min
Master's in Pharmacy & Pharmaceutical Sciences in Ireland: Complete 2026 Guide for International Students
Pharmaceutical
Master's in Pharmacy & Pharmaceutical Sciences in Ireland: Complete 2026 Guide for International Students
An exhaustive guide detailing postgraduate Level 9 pharmaceutical master's programs across Irish universities, covering tuition fees, eligibility criteria, and requirements for international applicants.
29 Jun 2026 5 min
The Science of Cleanroom Classification: Understanding ISO 14644-1 Standards in Sterile Processing
Pharmaceutical
The Science of Cleanroom Classification: Understanding ISO 14644-1 Standards in Sterile Processing
An academic overview of cleanroom design parameters, particulate limits under ISO 14644-1, laminar airflow dynamics, and Grade A-D cleanroom zoning.
29 Jun 2026 4 min
ASCO 2026 Highlights: Landmark Clinical Data Points to Survival Extensions in Pancreatic and Lung Cancers
Clinical Trials
ASCO 2026 Highlights: Landmark Clinical Data Points to Survival Extensions in Pancreatic and Lung Cancers
The annual ASCO conference has delivered landmark clinical trial results, bringing promising survival extensions for pancreatic cancer and targeted lung cancer therapies.
29 Jun 2026 6 min
From Pilots to Infrastructure: How AI is Becoming the Core Operating System for Biopharma R&D in 2026
MedTech
From Pilots to Infrastructure: How AI is Becoming the Core Operating System for Biopharma R&D in 2026
Artificial intelligence has evolved from sandbox pilot projects to become the default operating system driving drug discovery, clinical trials, and sterile manufacturing.
29 Jun 2026 6 min
Global Biopharma M&A Rebounds in 2026: AbbVie and Merck KGaA Lead Multi-Billion Dollar Acquisitions
Industry
Global Biopharma M&A Rebounds in 2026: AbbVie and Merck KGaA Lead Multi-Billion Dollar Acquisitions
Global pharmaceutical dealmaking has surged in 2026 as cash-rich majors AbbVie and Merck KGaA close multi-billion dollar acquisitions to restock pipelines ahead of late-decade patent cliffs.
29 Jun 2026 6 min